Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA: 603392)
China
· Delayed Price · Currency is CNY 69.31
-1.37 (-1.94%)
Jan 6, 2025, 2:15 PM CST
Beijing Wantai Biological Pharmacy Enterprise Market Cap
Beijing Wantai Biological Pharmacy Enterprise has a market cap or net worth of 88.17 billion as of January 6, 2025. Its market cap has increased by 46.82% in one year.
Market Cap
88.17B
Enterprise Value
83.13B
Revenue
2.49B
Ranking
n/a
PE Ratio
n/a
Stock Price
69.31
Market Cap Chart
Since April 29, 2020, Beijing Wantai Biological Pharmacy Enterprise's market cap has increased from 5.46B to 88.17B, an increase of 1,513.78%. That is a compound annual growth rate of 81.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 3, 2025 | 89.42B | 0.31% |
| Dec 31, 2024 | 89.14B | -6.44% |
| Dec 29, 2023 | 95.28B | -17.00% |
| Dec 30, 2022 | 114.80B | -14.62% |
| Dec 31, 2021 | 134.46B | 53.87% |
| Dec 31, 2020 | 87.38B | 1,499.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 294.68B |
| Jiangsu Hengrui Medicine | 282.07B |
| WuXi AppTec | 150.20B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.98B |
| Aier Eye Hospital Group | 116.12B |
| Shanghai United Imaging Healthcare | 103.88B |
| Yunnan Baiyao Group Co.,Ltd | 103.36B |
| Sichuan Biokin Pharmaceutical Co.,Ltd. | 76.41B |